Answer
Pulmonary embolism (PE), deep vein thrombosis (DVT) and cerebral venous sinus thrombosis (CVT) have been reported in clinical trials of Leqselvi (deuruxolitinib phosphate).
Sources for this answer
- Leqselvi 8 mg film-coated tabletsRanbaxy (UK) Limited a Sun Pharmaceutical Company · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked